Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice - Test2 - elhamkhani - TriplyDB

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice

http://www.wikidata.org/entity/Q37230895

about

Assessment of [125I]WYE-230949 as a novel histamine H3 receptor radiopharmaceutical Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Ligand autoradiographical quantification of histamine H3 receptor in human dementia with Lewy bodies.Current therapeutic targets for the treatment of Alzheimer's disease.The neglected role of histamine in Alzheimer's disease.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Monoaminergic neuropathology in Alzheimer's disease.The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats.Advances in histamine pharmacology reveal new drug targets.Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.Therapeutics of Neurotransmitters in Alzheimer's Disease.

P2860

Q28542876-E75EB20E-2352-46E0-BA0C-3C042974512C Q30462161-87DEEC78-2BE6-42B7-B70A-9D0FF97FA156 Q33909909-22CE9E93-4432-4F67-8FC3-90C7CADE83D5 Q37420711-D6F48102-00BB-476C-8390-B3783BB96C5F Q37737296-2555D4A3-B261-44FA-80C9-711145B4B130 Q38107173-057EB152-A039-4FAC-8D38-69C88A330979 Q38286222-AA14154D-80BF-427C-A76F-BBA49B678E77 Q38809649-F42D36C9-44F1-45DC-BD86-377F1BCCC419 Q42691812-176D3BE7-F748-483C-AE79-FA78B1201587 Q43110514-F29E8363-81AA-47F8-B311-C900AAEFA10E Q47730256-9C919E96-DD11-4F47-B93E-26463F64D1B8 Q49672905-95283388-9054-414A-9A33-F26118B95530

P2860

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice

http://www.wikidata.org/entity/Q37230895

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Characterization of histamine ...... id over-expressing TASTPM mice

@en

Characterization of histamine ...... d over-expressing TASTPM mice.

@nl

type

label

Characterization of histamine ...... id over-expressing TASTPM mice

@en

Characterization of histamine ...... d over-expressing TASTPM mice.

@nl

prefLabel

Characterization of histamine ...... id over-expressing TASTPM mice

@en

Characterization of histamine ...... d over-expressing TASTPM mice.

@nl

P1433

Q37230895-0325A2E8-D9E9-44C5-BCCC-854E9F4C0C10

P1476

Q37230895-2BB5A88D-E8BD-4CFA-BC7F-13A0D3A8C563

P2093

Q37230895-00FA0A65-955B-4B34-8842-4E17D095E3EB

Q37230895-10442EBA-2357-45CB-A292-BB86157D67E6

Q37230895-11E9634E-16B2-4B53-8882-177F52F2C12C

Q37230895-CAA04CDE-6745-42D7-9790-E9C219E432BF

Q37230895-CBBB0CA7-0957-47FB-B62B-E6B1E6C07AA9

Q37230895-DCB2B0AA-6A1B-44FD-A2FD-8A8B04FB6287

P2860

Q37230895-0EF63B0F-3DF0-4BA0-B558-D75F246335B5

Q37230895-1161C9C2-D9BA-4652-8323-6A795B9AFE98

Q37230895-156C0559-1820-4CD8-93B6-FB705E0B93E1

Q37230895-1D58E015-4F4C-479A-9ED8-A86FC3381307

Q37230895-20EED464-1B0A-4F6F-9E2D-E29DF10EA12B

Q37230895-270AFFFD-DE0E-493B-AF12-E24D494D344E

Q37230895-315B8864-77FE-457A-926C-C45B3B011E59

Q37230895-3ECB3822-73E7-4081-9C90-8D134CD2FE87

Q37230895-40D76653-C059-4876-9FBF-7CC5D115A128

Q37230895-49791F1D-782D-4567-93BB-F4F726267686

P304

Q37230895-7F62802A-8D3E-420D-A8F0-97DB5CEA1A84

P31

Q37230895-4F3E7635-9304-40DD-A21D-D3D11755882C

P356

Q37230895-2958CDDF-E5F8-48BD-B00A-E77C2156D756

P407

Q37230895-2F995ACF-0035-46ED-B400-DFE32C434FDA

P433

Q37230895-D671899A-DB87-4F4E-B3FA-A6445C08461B

P478

Q37230895-CCECF8CA-5F59-4DD8-B116-18BAA19B2C52

P50

Q37230895-78264292-D286-424E-A16F-BDDAAEA7C31F

P577

Q37230895-1274FFBC-DAC2-4CD1-8AC7-4296292EC0FC

P5875

Q37230895-D5E7BBD8-4A28-4E81-A888-F9EEEB851676

P698

Q37230895-852DBAA9-3F0C-4C3E-AF5D-400B7B3541E3

P921

Q37230895-FDC41387-DA31-484B-8264-9CCBCC7D1100

P932

Q37230895-23ACB1CA-B5E6-4D68-BF5F-3994DB3A2475

P356

J.1476-5381.2008.00075.X

P1433

British Journal of Pharmacology

P1476

Characterization of histamine ...... id over-expressing TASTPM mice

@en

P2093

A D Medhurst

http://www.w3.org/2001/XMLSchema#string

C P L-H Chen

http://www.w3.org/2001/XMLSchema#string

J C Roberts

http://www.w3.org/2001/XMLSchema#string

J Lee

http://www.w3.org/2001/XMLSchema#string

S H Brown

http://www.w3.org/2001/XMLSchema#string

S Roman

http://www.w3.org/2001/XMLSchema#string

P2860

The histamine H3 receptor: an attractive target for the treatment of cognitive disorders

Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist

“Mini-mental state”

Neuropathological stageing of Alzheimer-related changes

Modulation of neurotransmitter release via histamine H3 heteroreceptors

Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system

The cholinergic hypothesis of geriatric memory dysfunction

The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

P304

130-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2008.00075.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell K.p. Lai

P577

2009-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24020487

http://www.w3.org/2001/XMLSchema#string

P698

19222483

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2697792

http://www.w3.org/2001/XMLSchema#string